Cargando…
A review on the advances and challenges of immunotherapy for head and neck cancer
Head and neck cancer (HNC), which includes lip and oral cavity, larynx, nasopharynx, oropharynx, and hypopharynx malignancies, is one of the most common cancers worldwide. Due to the interaction of tumor cells with immune cells in the tumor microenvironment, immunotherapy of HNCs, along with traditi...
Autores principales: | Cheng, Gang, Dong, Hui, Yang, Chen, Liu, Yang, Wu, Yi, Zhu, Lifen, Tong, Xiangmin, Wang, Shibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325213/ https://www.ncbi.nlm.nih.gov/pubmed/34332576 http://dx.doi.org/10.1186/s12935-021-02024-5 |
Ejemplares similares
-
Identification of CD206 as a potential biomarker of cancer stem-like cells and therapeutic agent in liver cancer
por: Fan, Weimin, et al.
Publicado: (2019) -
Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019) -
Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages
por: Dong, Hui, et al.
Publicado: (2023) -
Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
por: Qian, Jack M., et al.
Publicado: (2021) -
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
por: Saddawi-Konefka, Robert, et al.
Publicado: (2021)